檢索結果 - Marie O’Farrell

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
    Fatty acid synthase – Modern tumor cell biology insights into a classical oncology target

    Fatty acid synthase – Modern tumor cell biology insights into a classical oncology target 由 Douglas Buckley, Gregory Duke, Timothy S. Heuer, Marie O’Farrell, Allan S. Wagman, William McCulloch, George Kemble

    出版 2017
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models

    FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models 由 Marie O’Farrell, G M Duke, R. Webster Crowley, Douglas Buckley, Eduardo B. Martins, Dipankar Bhattacharya, Scott L. Friedman, George Kemble

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD–positive leukemic cells

    Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD–positive leukemic cells 由 Kevin Yee, Marcus M. Schittenhelm, Anne-Marie O'Farrell, Ajia Town, Laura McGreevey, Troy Bainbridge, Julie M. Cherrington, Michael C. Heinrich

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification

    Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification 由 Samuel E. DePrimo, Lily Wong, Deepak Khatry, Susan L Nicholas, William C. Manning, Beverly D. Smolich, Anne-Marie O’Farrell, Julie M. Cherrington

    出版 2003
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial

    Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial 由 Rohit Loomba, Pierre Bédossa, Katharine Grimmer, George Kemble, Eduardo B. Martins, William McCulloch, Marie O’Farrell, Wen-Wei Tsai, Jose Cobiella, Eric Lawitz, Madhavi Rudraraju, Stephen A. Harrison

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Therapeutic efficacy of FASN inhibition in preclinical models of HCC

    Therapeutic efficacy of FASN inhibition in preclinical models of HCC 由 Haichuan Wang, Yi Zhou, Hongwei Xu, Xue Wang, Yi Zhang, Runze Shang, Marie O’Farrell, Stephanie Roessler, Carsten Sticht, Andreas Stahl, Matthias Evert, Diego F. Calvisi, Yong Zeng, Xin Chen

    出版 2022
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    p21-Activated Kinase 1 Is Required for Efficient Tumor Formation and Progression in a Ras-Mediated Skin Cancer Model

    p21-Activated Kinase 1 Is Required for Efficient Tumor Formation and Progression in a Ras-Mediated Skin Cancer Model 由 Hoi Yee Chow, Adrian M. Jubb, Jennifer N. Koch, Zahara M. Jaffer, Dina Stepanova, David A. Campbell, Sergio G. Durón, Marie O’Farrell, Kathy Q. Cai, Andres J. Klein–Szanto, J. Silvio Gutkind, Klaus P. Hoeflich, Jonathan Chernoff

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

    SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo 由 Anne-Marie O'Farrell, Tinya J. Abrams, Helene A. Yuen, Theresa J. Ngai, Sharianne G. Louie, Kevin Yee, Lily Wong, Weiru Hong, Leslie B. Lee, Ajia Town, Beverly D. Smolich, William C. Manning, Lesley Murray, Michael C. Heinrich, Julie M. Cherrington

    出版 2003
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors

    First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors 由 Gerald S. Falchook, Jeffrey R. Infante, Hendrik‐Tobias Arkenau, Manish R. Patel, Emma Dean, Erkut Borazanci, Andrew Brenner, Natalie Cook, Juanita Lopez, Shubham Pant, Arthur E. Frankel, Peter Schmid, Kathleen N. Moore, William McCulloch, Katharine Grimmer, Marie O’Farrell, George Kemble, Howard A. Burris

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes

    SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes 由 Francis J. Giles, Alison Stopeck, Lewis R. Silverman, Jeffrey E. Lancet, Maureen Cooper, Alison L. Hannah, Julie M. Cherrington, Anne-Marie O'Farrell, Helene A. Yuen, Sharianne G. Louie, Weiru Hong, Jorge E. Cortés, Srđan Verstovšek, Maher Albitar, Susan O’Brien, Hagop M. Kantarjian, Judith E. Karp

    出版 2003
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial

    TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial 由 Rohit Loomba, Rizwana Mohseni, Kathryn Jean Lucas, Julio Gutiérrez, Robert G. Perry, James F. Trotter, Robert S. Rahimi, Stephen A. Harrison, Veeral Ajmera, Jeffrey D. Wayne, Marie O’Farrell, William McCulloch, Katharine Grimmer, Mary E. Rinella, Vincent Wai‐Sun Wong, Vlad Ratziu, Gregory J. Gores, Brent A. Neuschwander‐Tetri, George Kemble

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Fatty acid synthesis suppresses dietary polyunsaturated fatty acid use

    Fatty acid synthesis suppresses dietary polyunsaturated fatty acid use 由 Anna Worthmann, Julius Ridder, Sharlaine Piel, Ioannis Evangelakos, Melina Musfeldt, Hannah Voß, Marie O’Farrell, Alexander W. Fischer, Sangeeta Adak, Monica Sundd, Hasibullah Siffeti, Friederike Haumann, Katja Kloth, Tatjana Bierhals, Markus Heine, Paul Pertzborn, Mira Pauly, Julia-Josefine Scholz, Suman Kundu, Marceline M. Fuh, Axel Neu, Klaus Tödter, Maja Hempel, Uwe Knippschild, Clay F. Semenkovich, Hartmut Schlüter, Jöerg Heeren, Ludger Scheja, Christian Kubisch, Christian Schlein

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: